Euclidean Capital LLC
NEW YORK, NY · CIK 1825034 · 13F filing filed 2022-08-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityEUCLIDEAN CAPITAL LLC (US)
- Others nearbyNew York, NY
$117.6m
reported value
-31.7% vs Q1 2022
10positions
100.0%in top 10
0 new
0 added
0 reduced
1 sold out
vs Q1 2022
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| PMV PHARMACEUTICALS INC PMVP | $33.3m28.32% | Unchanged |
| 23ANDME HOLDING CO CLASS A COM | $25.4m21.61% | Unchanged |
| FOGHORN THERAPEUTICS INC FHTX | $17.2m14.59% | Unchanged |
| ALECTOR INC ALEC | $10.0m8.48% | Unchanged |
| NGM BIOPHARMACEUTICALS INC NGM | $9.6m8.14% | Unchanged |
| RAPT THERAPEUTICS INC COM | $7.9m6.72% | Unchanged |
| TENAYA THERAPEUTICS INC TNYA | $5.2m4.38% | Unchanged |
| FIRST FINL BANCORP OH FFBC | $3.4m2.86% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $3.3m2.85% | Unchanged |
| SURROZEN INC COM | $2.4m2.05% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| COINBASE GLOBAL INC COIN | $8.9m46.9k shares |